Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interstitial pneumonia caused by dabigatran.
Yanagihara T, Yamamoto N, Kotetsu Y, Hamada N, Harada E, Suzuki K, Ijichi K, Oda Y, Nakanishi Y. Yanagihara T, et al. Among authors: yamamoto n. Respir Med Case Rep. 2017 Oct 31;23:10-12. doi: 10.1016/j.rmcr.2017.10.009. eCollection 2018. Respir Med Case Rep. 2017. PMID: 29159033 Free PMC article.
Relative age effect on the physical activity and sedentary behavior in children and adolescents aged 10 to 18 years old: a cross-sectional study in Japan.
Mori T, Aoki T, Oishi K, Harada T, Tanaka C, Tanaka S, Tanaka H, Fukuda K, Kamikawa Y, Tsuji N, Komura K, Kokudo S, Morita N, Suzuki K, Watanabe M, Kasanami R, Hara T, Miyazaki R, Abe T, Yamatsu K, Kume D, Asai H, Yamamoto N, Tsuji T, Nakaya T, Ishii K. Mori T, et al. Among authors: yamamoto n. BMC Public Health. 2024 Nov 25;24(1):3273. doi: 10.1186/s12889-024-20659-7. BMC Public Health. 2024. PMID: 39587539 Free PMC article.
Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology.
Murakami M, Miyata Y, Nakashima K, Abe M, Nishimura J, Wada M, Iino K, Akechi T, Iihara H, Imamura CK, Okuyama A, Ozawa K, Kim YI, Sasaki H, Satomi E, Takeda M, Tanaka R, Nakamura N, Noda M, Hayashi K, Higashi T, Boku N, Matsumoto K, Matsumoto Y, Okita K, Yamamoto N, Aogi K, Nakajima TE. Murakami M, et al. Among authors: yamamoto n. Int J Clin Oncol. 2024 Nov 21. doi: 10.1007/s10147-024-02663-4. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39570460
6,373 results